New topical hair loss treatment shows a 539% improvement in trials, offering hope for male-pattern baldness sufferers after ...

Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...

A treatment for alopecia areata could move forward despite a setback in a midstage clinical trial.

Dr. Hordinsky discusses how clascoterone 5% topical solution may reshape male AGA management and expand treatment confidence.

Here are the top 5 most-viewed alopecia content in 2025.

Despite being unable to declare statistical success, the company claimed its therapy showed enough promise to support moving ...

Alison Lee felt a slight tug at the back of her head. Her dark wig slipped off in an instant, revealing her hairless scalp to the shining sun, the cool breeze, and her entire third-grade class during ...

In two large late-stage clinical trials, the company’s experimental drug clascoterone triggered significant hair regrowth in ...

After they lost their hair, they found their voices. Now, two local teens and their families want to raise awareness about a lesser-known treatment for the condition that once robbed them of their ...

The U.S. Food and Drug Administration on Friday approved an alopecia treatment for kids, marking a historic first. The drug, ritlecitinib, is a once-daily pill for kids ages 12 and older with severe ...

An expert consensus by Spanish dermatologists offers treatment recommendations for androgenetic alopecia, the most common cause of hair loss, using a combination of medications and hair ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Ritlecitinib, an oral JAK 3 inhibitor, was effective for ...